Suchergebnisse - "Myeloma"

PubPharm (2.923)

21

Targeting NKG2D/NKG2DL axis in multiple myeloma therapy

enthalten in: Cytokine & growth factor reviews | 2024

von Liu, Z. | Wang, H. | Liu, H. | +4

22

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

23

Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study

enthalten in: Cancer | 2024

von Nooka, A. | Rodriguez, C. | Mateos, M. | +9

24

Bortezomib modulated the autophagy-lysosomal pathway in a TFEB-dependent manner in multiple myeloma

enthalten in: Leukemia research | 2024

von Zhang, R. | Yang, X. | Shi, X. | +4

25

Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM)

enthalten in: Cell communication and signaling : CCS | 2024

von Du, J. | Lin, Z. | Fu, X. | +3

26

Geriatric assessment-guided interventions for older adults with multiple myeloma : A feasibility and acceptability study

enthalten in: Journal of geriatric oncology | 2024

von Jensen, C. | Deal, A. | Nyrop, K. | +8

27

Laboratory practice is central to earlier myeloma diagnosis : Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services

enthalten in: British journal of haematology | 2024

von Drayson, M. | Jennis, T. | Laketic-Ljubojevic, I. | +11

CommentIn: Br J Haematol. 2024 Feb;204(2):393-394. - PMID 38168005

28

Lymphoid blood cancers, incidence and survival 2005-2023 : A report from the UK's Haematological Malignancy Research Network

enthalten in: Cancer epidemiology | 2024

von Lamb, M. | Painter, D. | Howell, D. | +8

29

A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma

enthalten in: Current medical research and opinion | 2024

von Mol, I. | Hu, Y. | LeBlanc, T. | +6

30

An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma

enthalten in: British journal of haematology | 2024

von Li, M. | Bennett, M. | Toubia, J. | +8